During the past decade, Heart Center Bad Krozingen conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heart Center Bad Krozingen" #1 sponsor was "University Heart Center Freiburg - Bad Krozingen" with 2 trials, followed by "Corvia Medical" with 1 trials sponsored, "Dr. Sabrina Overhagen" with 1 trials sponsored, "Faculty Hospital Kralovske Vinohrady" with 1 trials sponsored and "Jena University Hospital" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Center Bad Krozingen" #1 collaborator was "Charles University, Czech Republic" with 2 trials as a collaborator, "German Heart Center" with 2 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 2 trials as a collaborator, "University Heart Center Freiburg - Bad Krozingen" with 2 trials as a collaborator and "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "Heart Center Bad Krozingen" are "Coronary Artery Disease" (3 trials), "Cardiogenic Shock" (2 trials), "Drug Resistance" (2 trials), "ARDS, Human" (1 trials) and "Abdominal Aortic Aneurysm, Without Mention of Rupture" (1 trials). Many other conditions were trialed in "Heart Center Bad Krozingen" in a lesser frequency.

Most popular intervention types in "Heart Center Bad Krozingen" are "Device" (5 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adjustment of clopidogrel dose" (1 trials), "BeGraft Peripheral (BGP) Stent Graft System as bridging stent" (1 trials), "Cangrelor" (1 trials), "Clopidogrel" (1 trials) and "Endeavor Resolute Zotarolimus-Eluting Coronary Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Center Bad Krozingen" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Heart Center Bad Krozingen". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Heart Center Bad Krozingen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heart Center Bad Krozingen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".